Disparities in pediatric psychosocial oncology utilization

Daniel J Zheng1,2,3, Puja J Umaretiya4,5,6, Emily R Schwartz7,8

  • 1Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.

Pediatric Blood & Cancer
|September 14, 2021
PubMed

Insights

Integrated behavioral health models in pediatric oncology did not show disparities in psychiatry use based on socioeconomic status. However, racial and ethnic minority children were less likely to receive psychiatric consultations, indicating a persistent disparity in care.

Area of Science:

  • Pediatric Oncology
  • Health Services Research
  • Mental Health Disparities

Background:

  • Integrated behavioral health models aim to reduce mental health disparities in primary care.
  • These models are understudied in pediatric oncology medical homes.

Purpose of the Study:

  • To evaluate psychiatry utilization in a pediatric oncology medical home with an integrated behavioral health model.
  • To identify disparities in mental health service access among children with cancer.

Main Methods:

  • Retrospective cohort study of 394 children with newly diagnosed cancer.
  • Data collected on sociodemographics, household material hardship (HMH), and psychiatry utilization within 12 months postdiagnosis.
  • Multivariable logistic regression used to assess associations.

Main Results:

  • 29% of children received a psychiatric consultation within 12 months.
  • No significant association found between socioeconomic status (HMH, income) and psychiatry utilization.
  • Racial/ethnic minority children were significantly less likely to receive a psychiatric consultation (OR=0.48).

Conclusions:

  • Socioeconomic status did not drive disparities in psychiatry utilization within this integrated model.
  • A significant racial/ethnic disparity in psychiatry utilization persists.
  • Further research and interventions are needed to address racial/ethnic disparities in pediatric oncology behavioral health access.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
44
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
40
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
49
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
141
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
39
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
34